Review



comet assay kit  (Beyotime)


Bioz Verified Symbol Beyotime is a verified supplier
Bioz Manufacturer Symbol Beyotime manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Beyotime comet assay kit
    Comet Assay Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 215 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/comet+assay+kit/Comet+Assay+Kit/pm42833030-103-13-17
    Average 99 stars, based on 215 article reviews
    comet assay kit - by Bioz Stars, 2026-10
    99/100 stars

    Images

    Related Articles

    Single Cell Gel Electrophoresis:

    Article Title: PGK1/PHGDH axis drives radioresistance in glioblastoma stem cells.
    Article Snippet: Glioblastoma (GBM) is the most aggressive primary brain tumor in adults, and radiotherapy is a key treatment option.. However, glioblastoma stem cells (GSCs) can develop resistance to radiotherapy through metabolic reprogramming, which often results in tumor recurrence.. Here we found that glycolytic enzyme phosphoglycerate kinase 1 (PGK1) was phosphorylated at threonine 8 (T8) by ataxia telangiectasia mutated (ATM) upon irradiation (IR), leading to enhanced binding of PGK1 to phosphoglycerate dehydrogenase (PHGDH), the ratelimiting enzyme for the serine synthesis pathway (SSP).

    Article Title: Root sequestration and antioxidant defense underpin cadmium tolerance in Arundo donax under contrasting Cd concentrations.
    Article Snippet: Protoplasts were isolated using a plant protoplast isolation kit (C0362S, Beyotime, Shanghai, China). .. The comet assay was subsequently conducted following the manufacturer’s instructions with a commercial comet assay kit (C2041S, Beyotime, Shanghai, China). .. Each slide was stained with 20 μL of 3 μM propidium iodide (PI) and examined under a fluorescence microscope (BX43, Olympus, Tokyo, Japan) equipped with a 535/617 nm excitation/emission filter set.

    Article Title: The degradation of antibiotic resistance gene in fresh produce using plasma-activated water
    Article Snippet: .. The Comet Assay kit (Beyotime, China) was used to detect the DNA damage. ..

    Article Title: From phthalate exposure to venous thrombotic risk: Decoding the DEHP-ROS mediated OTUD1- p53 stabilization loop in endothelium.
    Article Snippet: .. The comet assay was performed by using Comet Assay Kit (Beyotime, China). ..

    Article Title: Arginine dependency in omental metastasis of epithelial ovarian cancer reveals a therapeutic vulnerability.
    Article Snippet: Imaging was performed using a JEOL JSM-IT700HR scanning electron microscope. .. Comet assay The comet assay kit (Cat. No. C2041M, Beyotime, Shanghai, China) was used to detect DNA damage in single cells. .. Imaging was performed using a JEOL JSM-IT700HR scanning electron microscope.

    Article Title: KIF4A stabilizes TDP43 to promote DNA damage repair and temozolomide resistance in glioblastoma.
    Article Snippet: Temozolomide (TMZ) resistance remains a major obstacle to effective glioblastoma (GBM) treatment and is closely linked to enhanced DNA damage repair.. Kinesin family member 4A (KIF4A) has been implicated in tumor progression, but its role in TMZ resistance remains unclear.. In this study, KIF4A and TAR DNA-binding protein 43 (TDP43) expression and prognostic significance were analyzed using The Cancer Genome Atlas glioma cohort and clinical specimens.

    other:

    Article Title: Oxidative Stress, DNA Damage, DNA Repair Inhibition, and Apoptosis Induced by Lead and Cadmium Combined Exposure in TK6 Cells.
    Article Snippet: γ-H2AX fluorescence intensity was analyzed using ImageJ 150i software, (https://imagej.net/ij/, accessed on 8 April 2026).

    Article Title: Oxidative Stress, DNA Damage, DNA Repair Inhibition, and Apoptosis Induced by Lead and Cadmium Combined Exposure in TK6 Cells
    Article Snippet: γ-H2AX fluorescence intensity was analyzed using ImageJ 150i software, ( https://imagej.net/ij/ , accessed on 8 April 2026).

    Single Cell:

    Article Title: KIF4A stabilizes TDP43 to promote DNA damage repair and temozolomide resistance in glioblastoma.
    Article Snippet: Temozolomide (TMZ) resistance remains a major obstacle to effective glioblastoma (GBM) treatment and is closely linked to enhanced DNA damage repair.. Kinesin family member 4A (KIF4A) has been implicated in tumor progression, but its role in TMZ resistance remains unclear.. In this study, KIF4A and TAR DNA-binding protein 43 (TDP43) expression and prognostic significance were analyzed using The Cancer Genome Atlas glioma cohort and clinical specimens.



    Similar Products

    99
    Beyotime comet assay kit
    Comet Assay Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/comet+assay+kit/Comet+Assay+Kit/pm42833030-103-13-17
    Average 99 stars, based on 1 article reviews
    comet assay kit - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Advanced Cell Diagnostics Inc rnascope hiplex pro
    (A) Pan-cancer ranking of mean GSDME expression across 30 solid tumor types from TCGA, ordered by decreasing GSDME expression (left). Effect sizes and statistical significance for tissue-level comparisons of gasdermin family member expression between GBM tumor tissue and normal brain tissue from TCGA are shown (right). (B) UMAP visualization of scRNA-seq profiles from 12 GBM PDCLs, including six matched primary-recurrent pairs. CME037/CME038 and CME014/CME016 represent two matched primary-recurrent pairs. Bar plots show the composition of Neftel et al. GBM cellular states in these four PDCLs. (C) Immunoblot analysis of GSDME and GSDMD expression in CME037, CME038, and CME014. (D) Representative immunohistochemistry images of GSDME in normal cortex, low-grade glioma, and high-grade glioma from HPA (left), with quantification of GSDME optical density (OD) across the full cohort (right). (E) Dot plot showing expression of markers used for cell type annotation in the COMET study. (F) COMET images of tumoral (left) and periphery (right) tissue corresponding to the PDCL CME038, showing SOX2, GSDME, and DAPI. (G) Single cell comparison of GSDME RNA expression measured by <t>RNAscope</t> (left) and GSDME protein intensity measured by COMET staining (right) across annotated cell types in the in-house COMET cohort. (H) COMET images of tumor tissue corresponding to the mesenchymal-dominant PDCL CME014, showing SOX2, GSDME, Iba1, TMEM119, and DAPI. (I) Representative COMET images of tumor tissue corresponding to PDCL CME037, showing total caspase-3, cleaved caspase-3, and DAPI (left), with single cell quantification of cleaved caspase-3 abundance across cell types in the full cohort (right). (J) Patient demographic and clinical characteristics for the MILAN study cohort. (K) PCA visualization of all segmented cells from the MILAN study, colored by annotated cell type. (L) Dot plot showing expression of markers used for cell type annotation in the MILAN study. (M) Bar plots showing cell type composition for each image (top) and GSDME intensity per GBM cell in the corresponding image (bottom) in the MILAN study. Box plots show the median, interquartile range, and 10 th -90 th percentile whiskers. Statistical significance is indicated as ****p < 0.0001.
    Rnascope Hiplex Pro, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/comet+assay+kit/RNAscope+HiPlex+Pro+for+COMET+12-plex+Reagent+Kit/bio_rxiv__64898__2026__07__22__740157-312-6-14
    Average 99 stars, based on 1 article reviews
    rnascope hiplex pro - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Beyotime cometassay kit
    (A) Pan-cancer ranking of mean GSDME expression across 30 solid tumor types from TCGA, ordered by decreasing GSDME expression (left). Effect sizes and statistical significance for tissue-level comparisons of gasdermin family member expression between GBM tumor tissue and normal brain tissue from TCGA are shown (right). (B) UMAP visualization of scRNA-seq profiles from 12 GBM PDCLs, including six matched primary-recurrent pairs. CME037/CME038 and CME014/CME016 represent two matched primary-recurrent pairs. Bar plots show the composition of Neftel et al. GBM cellular states in these four PDCLs. (C) Immunoblot analysis of GSDME and GSDMD expression in CME037, CME038, and CME014. (D) Representative immunohistochemistry images of GSDME in normal cortex, low-grade glioma, and high-grade glioma from HPA (left), with quantification of GSDME optical density (OD) across the full cohort (right). (E) Dot plot showing expression of markers used for cell type annotation in the COMET study. (F) COMET images of tumoral (left) and periphery (right) tissue corresponding to the PDCL CME038, showing SOX2, GSDME, and DAPI. (G) Single cell comparison of GSDME RNA expression measured by <t>RNAscope</t> (left) and GSDME protein intensity measured by COMET staining (right) across annotated cell types in the in-house COMET cohort. (H) COMET images of tumor tissue corresponding to the mesenchymal-dominant PDCL CME014, showing SOX2, GSDME, Iba1, TMEM119, and DAPI. (I) Representative COMET images of tumor tissue corresponding to PDCL CME037, showing total caspase-3, cleaved caspase-3, and DAPI (left), with single cell quantification of cleaved caspase-3 abundance across cell types in the full cohort (right). (J) Patient demographic and clinical characteristics for the MILAN study cohort. (K) PCA visualization of all segmented cells from the MILAN study, colored by annotated cell type. (L) Dot plot showing expression of markers used for cell type annotation in the MILAN study. (M) Bar plots showing cell type composition for each image (top) and GSDME intensity per GBM cell in the corresponding image (bottom) in the MILAN study. Box plots show the median, interquartile range, and 10 th -90 th percentile whiskers. Statistical significance is indicated as ****p < 0.0001.
    Cometassay Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/comet+assay+kit/Comet+Assay+Kit/pm41821356-239-9-11
    Average 99 stars, based on 1 article reviews
    cometassay kit - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    86
    Amyjet Scientific Inc oxiselect comet assay kit
    (A) Pan-cancer ranking of mean GSDME expression across 30 solid tumor types from TCGA, ordered by decreasing GSDME expression (left). Effect sizes and statistical significance for tissue-level comparisons of gasdermin family member expression between GBM tumor tissue and normal brain tissue from TCGA are shown (right). (B) UMAP visualization of scRNA-seq profiles from 12 GBM PDCLs, including six matched primary-recurrent pairs. CME037/CME038 and CME014/CME016 represent two matched primary-recurrent pairs. Bar plots show the composition of Neftel et al. GBM cellular states in these four PDCLs. (C) Immunoblot analysis of GSDME and GSDMD expression in CME037, CME038, and CME014. (D) Representative immunohistochemistry images of GSDME in normal cortex, low-grade glioma, and high-grade glioma from HPA (left), with quantification of GSDME optical density (OD) across the full cohort (right). (E) Dot plot showing expression of markers used for cell type annotation in the COMET study. (F) COMET images of tumoral (left) and periphery (right) tissue corresponding to the PDCL CME038, showing SOX2, GSDME, and DAPI. (G) Single cell comparison of GSDME RNA expression measured by <t>RNAscope</t> (left) and GSDME protein intensity measured by COMET staining (right) across annotated cell types in the in-house COMET cohort. (H) COMET images of tumor tissue corresponding to the mesenchymal-dominant PDCL CME014, showing SOX2, GSDME, Iba1, TMEM119, and DAPI. (I) Representative COMET images of tumor tissue corresponding to PDCL CME037, showing total caspase-3, cleaved caspase-3, and DAPI (left), with single cell quantification of cleaved caspase-3 abundance across cell types in the full cohort (right). (J) Patient demographic and clinical characteristics for the MILAN study cohort. (K) PCA visualization of all segmented cells from the MILAN study, colored by annotated cell type. (L) Dot plot showing expression of markers used for cell type annotation in the MILAN study. (M) Bar plots showing cell type composition for each image (top) and GSDME intensity per GBM cell in the corresponding image (bottom) in the MILAN study. Box plots show the median, interquartile range, and 10 th -90 th percentile whiskers. Statistical significance is indicated as ****p < 0.0001.
    Oxiselect Comet Assay Kit, supplied by Amyjet Scientific Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/comet+assay+kit/assay+comet+electrophoresis+system/pmc13147429-54-33-37
    Average 86 stars, based on 1 article reviews
    oxiselect comet assay kit - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Cell Biolabs Inc oxiselect comet assay kit
    (A) Pan-cancer ranking of mean GSDME expression across 30 solid tumor types from TCGA, ordered by decreasing GSDME expression (left). Effect sizes and statistical significance for tissue-level comparisons of gasdermin family member expression between GBM tumor tissue and normal brain tissue from TCGA are shown (right). (B) UMAP visualization of scRNA-seq profiles from 12 GBM PDCLs, including six matched primary-recurrent pairs. CME037/CME038 and CME014/CME016 represent two matched primary-recurrent pairs. Bar plots show the composition of Neftel et al. GBM cellular states in these four PDCLs. (C) Immunoblot analysis of GSDME and GSDMD expression in CME037, CME038, and CME014. (D) Representative immunohistochemistry images of GSDME in normal cortex, low-grade glioma, and high-grade glioma from HPA (left), with quantification of GSDME optical density (OD) across the full cohort (right). (E) Dot plot showing expression of markers used for cell type annotation in the COMET study. (F) COMET images of tumoral (left) and periphery (right) tissue corresponding to the PDCL CME038, showing SOX2, GSDME, and DAPI. (G) Single cell comparison of GSDME RNA expression measured by <t>RNAscope</t> (left) and GSDME protein intensity measured by COMET staining (right) across annotated cell types in the in-house COMET cohort. (H) COMET images of tumor tissue corresponding to the mesenchymal-dominant PDCL CME014, showing SOX2, GSDME, Iba1, TMEM119, and DAPI. (I) Representative COMET images of tumor tissue corresponding to PDCL CME037, showing total caspase-3, cleaved caspase-3, and DAPI (left), with single cell quantification of cleaved caspase-3 abundance across cell types in the full cohort (right). (J) Patient demographic and clinical characteristics for the MILAN study cohort. (K) PCA visualization of all segmented cells from the MILAN study, colored by annotated cell type. (L) Dot plot showing expression of markers used for cell type annotation in the MILAN study. (M) Bar plots showing cell type composition for each image (top) and GSDME intensity per GBM cell in the corresponding image (bottom) in the MILAN study. Box plots show the median, interquartile range, and 10 th -90 th percentile whiskers. Statistical significance is indicated as ****p < 0.0001.
    Oxiselect Comet Assay Kit, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/comet+assay+kit/assay+comet+kit+oxiselect/pmc13264319-50-0-5
    Average 86 stars, based on 1 article reviews
    oxiselect comet assay kit - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Trevigen comet assay kit
    (A) Pan-cancer ranking of mean GSDME expression across 30 solid tumor types from TCGA, ordered by decreasing GSDME expression (left). Effect sizes and statistical significance for tissue-level comparisons of gasdermin family member expression between GBM tumor tissue and normal brain tissue from TCGA are shown (right). (B) UMAP visualization of scRNA-seq profiles from 12 GBM PDCLs, including six matched primary-recurrent pairs. CME037/CME038 and CME014/CME016 represent two matched primary-recurrent pairs. Bar plots show the composition of Neftel et al. GBM cellular states in these four PDCLs. (C) Immunoblot analysis of GSDME and GSDMD expression in CME037, CME038, and CME014. (D) Representative immunohistochemistry images of GSDME in normal cortex, low-grade glioma, and high-grade glioma from HPA (left), with quantification of GSDME optical density (OD) across the full cohort (right). (E) Dot plot showing expression of markers used for cell type annotation in the COMET study. (F) COMET images of tumoral (left) and periphery (right) tissue corresponding to the PDCL CME038, showing SOX2, GSDME, and DAPI. (G) Single cell comparison of GSDME RNA expression measured by <t>RNAscope</t> (left) and GSDME protein intensity measured by COMET staining (right) across annotated cell types in the in-house COMET cohort. (H) COMET images of tumor tissue corresponding to the mesenchymal-dominant PDCL CME014, showing SOX2, GSDME, Iba1, TMEM119, and DAPI. (I) Representative COMET images of tumor tissue corresponding to PDCL CME037, showing total caspase-3, cleaved caspase-3, and DAPI (left), with single cell quantification of cleaved caspase-3 abundance across cell types in the full cohort (right). (J) Patient demographic and clinical characteristics for the MILAN study cohort. (K) PCA visualization of all segmented cells from the MILAN study, colored by annotated cell type. (L) Dot plot showing expression of markers used for cell type annotation in the MILAN study. (M) Bar plots showing cell type composition for each image (top) and GSDME intensity per GBM cell in the corresponding image (bottom) in the MILAN study. Box plots show the median, interquartile range, and 10 th -90 th percentile whiskers. Statistical significance is indicated as ****p < 0.0001.
    Comet Assay Kit, supplied by Trevigen, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/comet+assay+kit/assay+comet+kit/pm42283915-250-6-9
    Average 86 stars, based on 1 article reviews
    comet assay kit - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Cell Biolabs Inc oxiselecttm comet assay kit
    (A) Pan-cancer ranking of mean GSDME expression across 30 solid tumor types from TCGA, ordered by decreasing GSDME expression (left). Effect sizes and statistical significance for tissue-level comparisons of gasdermin family member expression between GBM tumor tissue and normal brain tissue from TCGA are shown (right). (B) UMAP visualization of scRNA-seq profiles from 12 GBM PDCLs, including six matched primary-recurrent pairs. CME037/CME038 and CME014/CME016 represent two matched primary-recurrent pairs. Bar plots show the composition of Neftel et al. GBM cellular states in these four PDCLs. (C) Immunoblot analysis of GSDME and GSDMD expression in CME037, CME038, and CME014. (D) Representative immunohistochemistry images of GSDME in normal cortex, low-grade glioma, and high-grade glioma from HPA (left), with quantification of GSDME optical density (OD) across the full cohort (right). (E) Dot plot showing expression of markers used for cell type annotation in the COMET study. (F) COMET images of tumoral (left) and periphery (right) tissue corresponding to the PDCL CME038, showing SOX2, GSDME, and DAPI. (G) Single cell comparison of GSDME RNA expression measured by <t>RNAscope</t> (left) and GSDME protein intensity measured by COMET staining (right) across annotated cell types in the in-house COMET cohort. (H) COMET images of tumor tissue corresponding to the mesenchymal-dominant PDCL CME014, showing SOX2, GSDME, Iba1, TMEM119, and DAPI. (I) Representative COMET images of tumor tissue corresponding to PDCL CME037, showing total caspase-3, cleaved caspase-3, and DAPI (left), with single cell quantification of cleaved caspase-3 abundance across cell types in the full cohort (right). (J) Patient demographic and clinical characteristics for the MILAN study cohort. (K) PCA visualization of all segmented cells from the MILAN study, colored by annotated cell type. (L) Dot plot showing expression of markers used for cell type annotation in the MILAN study. (M) Bar plots showing cell type composition for each image (top) and GSDME intensity per GBM cell in the corresponding image (bottom) in the MILAN study. Box plots show the median, interquartile range, and 10 th -90 th percentile whiskers. Statistical significance is indicated as ****p < 0.0001.
    Oxiselecttm Comet Assay Kit, supplied by Cell Biolabs Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/comet+assay+kit/assay+comet+kit+oxiselect/pm42277179-74-3-7
    Average 86 stars, based on 1 article reviews
    oxiselecttm comet assay kit - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    Image Search Results


    (A) Pan-cancer ranking of mean GSDME expression across 30 solid tumor types from TCGA, ordered by decreasing GSDME expression (left). Effect sizes and statistical significance for tissue-level comparisons of gasdermin family member expression between GBM tumor tissue and normal brain tissue from TCGA are shown (right). (B) UMAP visualization of scRNA-seq profiles from 12 GBM PDCLs, including six matched primary-recurrent pairs. CME037/CME038 and CME014/CME016 represent two matched primary-recurrent pairs. Bar plots show the composition of Neftel et al. GBM cellular states in these four PDCLs. (C) Immunoblot analysis of GSDME and GSDMD expression in CME037, CME038, and CME014. (D) Representative immunohistochemistry images of GSDME in normal cortex, low-grade glioma, and high-grade glioma from HPA (left), with quantification of GSDME optical density (OD) across the full cohort (right). (E) Dot plot showing expression of markers used for cell type annotation in the COMET study. (F) COMET images of tumoral (left) and periphery (right) tissue corresponding to the PDCL CME038, showing SOX2, GSDME, and DAPI. (G) Single cell comparison of GSDME RNA expression measured by RNAscope (left) and GSDME protein intensity measured by COMET staining (right) across annotated cell types in the in-house COMET cohort. (H) COMET images of tumor tissue corresponding to the mesenchymal-dominant PDCL CME014, showing SOX2, GSDME, Iba1, TMEM119, and DAPI. (I) Representative COMET images of tumor tissue corresponding to PDCL CME037, showing total caspase-3, cleaved caspase-3, and DAPI (left), with single cell quantification of cleaved caspase-3 abundance across cell types in the full cohort (right). (J) Patient demographic and clinical characteristics for the MILAN study cohort. (K) PCA visualization of all segmented cells from the MILAN study, colored by annotated cell type. (L) Dot plot showing expression of markers used for cell type annotation in the MILAN study. (M) Bar plots showing cell type composition for each image (top) and GSDME intensity per GBM cell in the corresponding image (bottom) in the MILAN study. Box plots show the median, interquartile range, and 10 th -90 th percentile whiskers. Statistical significance is indicated as ****p < 0.0001.

    Journal: bioRxiv

    Article Title: Macrophage-instructed GSDME couples glioblastoma cell-state plasticity with inflammatory cell death

    doi: 10.64898/2026.07.22.740157

    Figure Lengend Snippet: (A) Pan-cancer ranking of mean GSDME expression across 30 solid tumor types from TCGA, ordered by decreasing GSDME expression (left). Effect sizes and statistical significance for tissue-level comparisons of gasdermin family member expression between GBM tumor tissue and normal brain tissue from TCGA are shown (right). (B) UMAP visualization of scRNA-seq profiles from 12 GBM PDCLs, including six matched primary-recurrent pairs. CME037/CME038 and CME014/CME016 represent two matched primary-recurrent pairs. Bar plots show the composition of Neftel et al. GBM cellular states in these four PDCLs. (C) Immunoblot analysis of GSDME and GSDMD expression in CME037, CME038, and CME014. (D) Representative immunohistochemistry images of GSDME in normal cortex, low-grade glioma, and high-grade glioma from HPA (left), with quantification of GSDME optical density (OD) across the full cohort (right). (E) Dot plot showing expression of markers used for cell type annotation in the COMET study. (F) COMET images of tumoral (left) and periphery (right) tissue corresponding to the PDCL CME038, showing SOX2, GSDME, and DAPI. (G) Single cell comparison of GSDME RNA expression measured by RNAscope (left) and GSDME protein intensity measured by COMET staining (right) across annotated cell types in the in-house COMET cohort. (H) COMET images of tumor tissue corresponding to the mesenchymal-dominant PDCL CME014, showing SOX2, GSDME, Iba1, TMEM119, and DAPI. (I) Representative COMET images of tumor tissue corresponding to PDCL CME037, showing total caspase-3, cleaved caspase-3, and DAPI (left), with single cell quantification of cleaved caspase-3 abundance across cell types in the full cohort (right). (J) Patient demographic and clinical characteristics for the MILAN study cohort. (K) PCA visualization of all segmented cells from the MILAN study, colored by annotated cell type. (L) Dot plot showing expression of markers used for cell type annotation in the MILAN study. (M) Bar plots showing cell type composition for each image (top) and GSDME intensity per GBM cell in the corresponding image (bottom) in the MILAN study. Box plots show the median, interquartile range, and 10 th -90 th percentile whiskers. Statistical significance is indicated as ****p < 0.0001.

    Article Snippet: RNA detection was performed using the RNAscope HiPlex Pro for COMET Reagent Kit (322075, Advanced Cell Diagnostics, Inc.).

    Techniques: Expressing, Western Blot, Immunohistochemistry, Single Cell, Comparison, RNA Expression, RNAscope, Staining

    (A) Nebulosa density plots and box plots show GSDME and GSDMD expression of CME037 maintained in monoculture or co-cultured with human macrophages. (B) Nebulosa density plots and box plots show GSDME and GSDMD expression of CME038 maintained in monoculture or co-cultured with human macrophages. (C) Nebulosa density plots and box plots show GSDME and GSDMD expression of LBT003 maintained in monoculture or co-cultured with human macrophages. (D) qPCR analysis of GSDME and GSDMD expression and immunoblots of GSDME expression in CME014 maintained in monoculture or indirectly co-cultured with THP-1-derived macrophages. (E) Immunoblot analysis of GSDME expression in CME037 and CME038 maintained in monoculture or indirectly co-cultured with THP-1 monocytic cells. (F) Bulk RNA-seq analysis of GSE136751 comparing GSDME and GSDMD expression in GBM cells maintained in monoculture or co-cultured with microglia. (G) Immunoblot analysis of GSDME expression in CME037, CME038, and CME014 maintained in monoculture or indirectly co-cultured with MHC3 microglia. (H) UMAP visualization of scRNA-seq profiles from macrophages maintained in monoculture or co-cultured with PDCLs from the experiment shown in (A) colored by culture condition and annotated using Miller et al. myeloid subtypes. Bar plots show myeloid subtype composition for each PDCL co-culture condition. (I) Bar plots showing cell subtype composition for each image in the MILAN study. (J) Single cell comparison of S100A4 RNA expression measured by RNAscope (left) and S100A4 protein intensity measured by COMET staining (right) across annotated cell types in the in-house COMET cohort. (K) Amphiregulin secretion in THP-1-macrophage monoculture, PDCL monoculture, and co-culture conditions, measured by nELISA. (L) Immunoblots of EGFRvIII expression across GBM PDCLs, including the PDCLs used in the co-culture experiments. (M) PDCL viability following treatment with erlotinib plicamycin, or ruxolitinib measured by CellTiter-Glo 2.0. (N) Immunoblots and quantification of EGFR, phosphorylated EGFR, STAT3, phosphorylated STAT3, and GSDME expression in CME037 maintained in monoculture with or without erlotinib treatment. (O) Immunoblots and quantification of the phosphorylated-to-total STAT3 ratio and GSDME expression following ruxolitinib treatment in the indirect co-culture system. Data are presented as mean ± SEM. Each dot in the bar plots represents an individual replicate. Statistical significance is indicated as *p < 0.05, **p < 0.01, and ****p < 0.0001.

    Journal: bioRxiv

    Article Title: Macrophage-instructed GSDME couples glioblastoma cell-state plasticity with inflammatory cell death

    doi: 10.64898/2026.07.22.740157

    Figure Lengend Snippet: (A) Nebulosa density plots and box plots show GSDME and GSDMD expression of CME037 maintained in monoculture or co-cultured with human macrophages. (B) Nebulosa density plots and box plots show GSDME and GSDMD expression of CME038 maintained in monoculture or co-cultured with human macrophages. (C) Nebulosa density plots and box plots show GSDME and GSDMD expression of LBT003 maintained in monoculture or co-cultured with human macrophages. (D) qPCR analysis of GSDME and GSDMD expression and immunoblots of GSDME expression in CME014 maintained in monoculture or indirectly co-cultured with THP-1-derived macrophages. (E) Immunoblot analysis of GSDME expression in CME037 and CME038 maintained in monoculture or indirectly co-cultured with THP-1 monocytic cells. (F) Bulk RNA-seq analysis of GSE136751 comparing GSDME and GSDMD expression in GBM cells maintained in monoculture or co-cultured with microglia. (G) Immunoblot analysis of GSDME expression in CME037, CME038, and CME014 maintained in monoculture or indirectly co-cultured with MHC3 microglia. (H) UMAP visualization of scRNA-seq profiles from macrophages maintained in monoculture or co-cultured with PDCLs from the experiment shown in (A) colored by culture condition and annotated using Miller et al. myeloid subtypes. Bar plots show myeloid subtype composition for each PDCL co-culture condition. (I) Bar plots showing cell subtype composition for each image in the MILAN study. (J) Single cell comparison of S100A4 RNA expression measured by RNAscope (left) and S100A4 protein intensity measured by COMET staining (right) across annotated cell types in the in-house COMET cohort. (K) Amphiregulin secretion in THP-1-macrophage monoculture, PDCL monoculture, and co-culture conditions, measured by nELISA. (L) Immunoblots of EGFRvIII expression across GBM PDCLs, including the PDCLs used in the co-culture experiments. (M) PDCL viability following treatment with erlotinib plicamycin, or ruxolitinib measured by CellTiter-Glo 2.0. (N) Immunoblots and quantification of EGFR, phosphorylated EGFR, STAT3, phosphorylated STAT3, and GSDME expression in CME037 maintained in monoculture with or without erlotinib treatment. (O) Immunoblots and quantification of the phosphorylated-to-total STAT3 ratio and GSDME expression following ruxolitinib treatment in the indirect co-culture system. Data are presented as mean ± SEM. Each dot in the bar plots represents an individual replicate. Statistical significance is indicated as *p < 0.05, **p < 0.01, and ****p < 0.0001.

    Article Snippet: RNA detection was performed using the RNAscope HiPlex Pro for COMET Reagent Kit (322075, Advanced Cell Diagnostics, Inc.).

    Techniques: Expressing, Cell Culture, Western Blot, Derivative Assay, RNA Sequencing, Co-Culture Assay, Single Cell, Comparison, RNA Expression, RNAscope, Staining

    (A) H&E image of a tumor core region from tumor tissue corresponding to PDCL CME037 (left) and corresponding COMET multiplexed staining for SOX2, GSDME, and DAPI, with a magnified region of interest showing SOX2, Iba1, α-SMA, GSDME, and DAPI. (B) Region of interest from (A) showing CD31, TMEM119, IL1B , CX3CR1 , MSR1 , C1QA , and DAPI (top), and a magnified image showing perivascular Iba1 + cells together with HMOX1 , IL1B , CX3CR1 , MSR1 , C1QA , S100A4 RNA, and S100A4 protein (bottom). (C) Schematic of the GSDME-expressing niche, comprising S100A4+ immunosuppressive macrophages, GSDME high GBM cells, and blood vessels. (D) H&E image of a pseudopalisading region from tumor tissue corresponding to PDCL CME037 (left) and corresponding COMET multiplexed staining for SOX2, EGFR, Iba1, α-SMA, and GSDME in the same tissue region. (E) Region of interest from (B) showing EGFR and OLIG2 staining (top) and CD163, α-SMA, and GSDME staining (bottom). (F) Magnified region of interest from c showing RNAscope staining for IL1B , CX3CR1 , MSR1 , C1QA , and S100A4 .

    Journal: bioRxiv

    Article Title: Macrophage-instructed GSDME couples glioblastoma cell-state plasticity with inflammatory cell death

    doi: 10.64898/2026.07.22.740157

    Figure Lengend Snippet: (A) H&E image of a tumor core region from tumor tissue corresponding to PDCL CME037 (left) and corresponding COMET multiplexed staining for SOX2, GSDME, and DAPI, with a magnified region of interest showing SOX2, Iba1, α-SMA, GSDME, and DAPI. (B) Region of interest from (A) showing CD31, TMEM119, IL1B , CX3CR1 , MSR1 , C1QA , and DAPI (top), and a magnified image showing perivascular Iba1 + cells together with HMOX1 , IL1B , CX3CR1 , MSR1 , C1QA , S100A4 RNA, and S100A4 protein (bottom). (C) Schematic of the GSDME-expressing niche, comprising S100A4+ immunosuppressive macrophages, GSDME high GBM cells, and blood vessels. (D) H&E image of a pseudopalisading region from tumor tissue corresponding to PDCL CME037 (left) and corresponding COMET multiplexed staining for SOX2, EGFR, Iba1, α-SMA, and GSDME in the same tissue region. (E) Region of interest from (B) showing EGFR and OLIG2 staining (top) and CD163, α-SMA, and GSDME staining (bottom). (F) Magnified region of interest from c showing RNAscope staining for IL1B , CX3CR1 , MSR1 , C1QA , and S100A4 .

    Article Snippet: RNA detection was performed using the RNAscope HiPlex Pro for COMET Reagent Kit (322075, Advanced Cell Diagnostics, Inc.).

    Techniques: Staining, Expressing, RNAscope

    (A) Correlation between GSDME and NINJ1 expression across pan-cancer cell lines from the CCLE dataset. (B) Odds ratio analysis of GSDME hi NINJ1 hi enrichment across pan-cancer cell lines. (C) Standardized GSDME expression per GBM cell in primary versus recurrent GBM samples from the MILAN cohort. (D) Box plots of CASP3 , GSDME and NINJ1 expression per GBM cell from primary versus recurrent GBM samples. (E) Hyp-PDT signature score in primary versus recurrent GBM. (F) Representative H&E image of the tumor-core region from the tumor corresponding to CME038, together with multiplexed COMET™ staining for SOX2, IBA1, GSDME, NINJ1 and α-SMA and RNAscope detection of MSR1 , C1QA and IL1B . (G) Expression of caspase-3, GSDME and NINJ1 in GBM cells binned by distance deciles from macrophages or endothelial cells as index cells. Box plots show the median, interquartile range, and 10 th -90 th percentile whiskers. Statistical significance is indicated as *p < 0.05, ****p < 0.0001.

    Journal: bioRxiv

    Article Title: Macrophage-instructed GSDME couples glioblastoma cell-state plasticity with inflammatory cell death

    doi: 10.64898/2026.07.22.740157

    Figure Lengend Snippet: (A) Correlation between GSDME and NINJ1 expression across pan-cancer cell lines from the CCLE dataset. (B) Odds ratio analysis of GSDME hi NINJ1 hi enrichment across pan-cancer cell lines. (C) Standardized GSDME expression per GBM cell in primary versus recurrent GBM samples from the MILAN cohort. (D) Box plots of CASP3 , GSDME and NINJ1 expression per GBM cell from primary versus recurrent GBM samples. (E) Hyp-PDT signature score in primary versus recurrent GBM. (F) Representative H&E image of the tumor-core region from the tumor corresponding to CME038, together with multiplexed COMET™ staining for SOX2, IBA1, GSDME, NINJ1 and α-SMA and RNAscope detection of MSR1 , C1QA and IL1B . (G) Expression of caspase-3, GSDME and NINJ1 in GBM cells binned by distance deciles from macrophages or endothelial cells as index cells. Box plots show the median, interquartile range, and 10 th -90 th percentile whiskers. Statistical significance is indicated as *p < 0.05, ****p < 0.0001.

    Article Snippet: RNA detection was performed using the RNAscope HiPlex Pro for COMET Reagent Kit (322075, Advanced Cell Diagnostics, Inc.).

    Techniques: Expressing, Staining, RNAscope